Picture of Vitrolife AB logo

VITR Vitrolife AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapNeutral

Momentum

Relative Strength (%)
1m+8.9%
3m+40%
6m-15.99%
1yr-33.4%
Volume Change (%)
10d/3m-48.29%
Price vs... (%)
52w High-47.56%
50d MA+13.56%
200d MA-14.66%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)68.83
PEG Ratio (f)3.54
EPS Growth (f)24.17%
Dividend Yield (f)0.42%
Valuation (ttm)IndustryMarket
Price to Book Value2.6
Price to Tang. Bookn/a
Price to Free Cashflow143.29
Price to Sales16.61
EV to EBITDA58.1

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital2.56%
Return on Equity3.85%
Operating Margin19.58%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueSEKm1,046.221,151.351,480.131,245.571,680.83,2323,764.3314.45%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+38.28+22.25+18.8-26.88+40.48-1.58+41.21n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Vitrolife AB EPS forecast chart

Profile Summary

Vitrolife AB is a Sweden-based company engaged in assisted reproduction services. The Company’s product portfolio comprises G-RINSE, which is a solution for rinsing of contact materials, EmbryoGlue, which is a human albumin recombinant, ASP, which is a solution for oocyte retrieval and rinsing, and Semen VTS, which is a viscosity treatment system, among others. It also provides a range of procedural solutions for sperm preparation, vitrification, embryo transfer and oocyte retrieval, such as temperature control, condition control, gamete-safe labware and embryo support. The Company is active in Australia, China, France, Italy, Japan, the United States and the United Kingdom, among others, and conducts its business through a number of subsidiaries, such as Vitrolife Ltd., Vitrolife Pty Ltd., and A.T.S. Srl.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
January 1st, 1970
Public Since
June 26th, 2001
No. of Shareholders
16,578
No. of Employees
1,162
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
se flag iconOMX Nordic Exchange Stockholm
Shares in Issue
135,394,622

VITR Share Price Performance

Upcoming Events for VITR

Q3 2022 Vitrolife AB Earnings Release

Q3 2022 Vitrolife AB Earnings Call

Q4 2022 Vitrolife AB Earnings Release

Q4 2022 Vitrolife AB Earnings Call

Similar to VITR

Picture of Acarix AB logo

Acarix AB

se flag iconOMX Nordic Exchange Stockholm

Picture of AdderaCare AB logo

AdderaCare AB

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of ADDvise AB (publ) logo

ADDvise AB (publ)

se flag iconOMX Nordic Exchange Stockholm

Picture of Aegirbio AB logo

Aegirbio AB

se flag iconOMX Nordic Exchange Stockholm

FAQ

Or unlock with your email

Or unlock with your email